EXOZYMES INC (EXOZ:NASDAQ)
$6.3015 0.1315 (2.1313%)
Analysed EXOZYMES INC (EXOZ:NASDAQ) News Sources
EXoZymes Inc (EXOZ) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
01-04-2026
yahoo.com
eXoZymes Provides Fourth Quarter and Full Year 2025 Update
31-03-2026
yahoo.com
eXoZymes CCO, Damien Perriman, Outlines NCTx Strategy and the Commercial Path for Cell-Free Biomanufacturing on Grow Everything Podcast
10-04-2026
yahoo.com
eXoZymes Announces Graduation from Shell GameChanger(TM) Accelerator Powered by NLR (GCxN) Program
07-05-2026
yahoo.com
eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants
08-06-2026
yahoo.com
eXoZymes Inc. Announces Closing of $6 Million Public Offering
17-06-2026
yahoo.com
eXoZymes to Host Second Quarter 2026 Update Conference Call on Thursday, August 20, 2026
11-08-2026
yahoo.com
MDB Capital Holdings LLC (MDBH) (Q2 2026) Earnings Call Highlights: Strategic Pivots and Asset ...
18-08-2026
yahoo.com
EXoZymes Inc (EXOZ) (Q2 2026) Earnings Call Highlights: Strategic Pivot and 10x Productivity ...
22-08-2026
yahoo.com
eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT
08-09-2026
yahoo.com
What is the current price of EXOZYMES INC (EXOZ:NASDAQ)?
The current price of EXOZYMES INC (EXOZ:NASDAQ) is $6.3015.
EXOZYMES INC (EXOZ:NASDAQ) absolute price change since previous trading day?
The absolute price change of EXOZYMES INC (EXOZ:NASDAQ) since the previous trading day is $0.1315.
EXOZYMES INC (EXOZ:NASDAQ) percentage price change since previous trading day?
The percentage price change of EXOZYMES INC (EXOZ:NASDAQ) since the previous trading day is 2.1313%.
What is the most recent average sentiment score for EXOZYMES INC (EXOZ:NASDAQ)?
The most recent average sentiment score for EXOZYMES INC (EXOZ:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for EXOZYMES INC (EXOZ:NASDAQ)?
The most recent sentiment for EXOZYMES INC (EXOZ:NASDAQ) is .
SEC-8K** Filing Available For EXOZYMES INC (EXOZ:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.